Open access · OA
via OpenAlex
Gut microbiome dysbiosis in metabolic disorders: implications for probiotics as prospective investigational new drugs
Baljinder Kaur, Praveen P. Balgir
JOURNAL OF GASTROINTESTINAL INFECTIONS · 2015
Abstract
Gut microbiome has been analysed using metagenomics approach which combines the power of genomics, bioinformatics, and systems biology, providing new ways to access the microbial world.Gut microbiome evolves from the pre-birth exposure onwards in a child, as a result of its interaction with its environment; and is apparently influenced by various environmental factors all through the life, most important being diet and its composition.Metagenomic analysis of gut microbial communities of a malnourished and a healthy child revealed an abundance of enteric pathogens leading to intestinal inflammation and nutrient malabsorption.The change in diet from vegetarian to non-vegetarian also influences the composition and dynamics of the intestinal microbes.Gut microbiota have been observed to vary with age due to physiological changes in the gastrointestinal tract, modifications in lifestyle, nutritional behavior and weakened functionality of the host immune system.Studies in apparently healthy individuals and patients suffering from intestinal or metabolic disorders revealed differential microbiome compositions, proving that an imbalance of gut microflora leads to dysbiosis which is the major cause of metabolic disorders such as irritable bowel syndrome (IBS), obesity, diarrhea, etc.The investigational studies are trying to assess the relationship between intestinal microbiota dysbiosis and various metabolic diseases.Nutritional interventions in the form of probiotics and prebiotics as investigational new drugs (INDs) are being assessed for correcting dysbiosis in disease states.The current paper focuses on the recent knowledge and databases for the same with pointers to future investigations as the need of the hour studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5005/jp-jogi-5-1-5
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Kaur, B., & Balgir, P.P. (2015). Gut microbiome dysbiosis in metabolic disorders: implications for probiotics as prospective investigational new drugs. <em>JOURNAL OF GASTROINTESTINAL INFECTIONS</em>. https://doi.org/10.5005/jp-jogi-5-1-5
Vancouver
Kaur B, Balgir PP. Gut microbiome dysbiosis in metabolic disorders: implications for probiotics as prospective investigational new drugs. JOURNAL OF GASTROINTESTINAL INFECTIONS. 2015. doi:10.5005/jp-jogi-5-1-5.
BibTeX
@article{baljinder2015Gutmic,
title = {Gut microbiome dysbiosis in metabolic disorders: implications for probiotics as prospective investigational new drugs},
author = {Baljinder Kaur and Praveen P. Balgir},
journal = {JOURNAL OF GASTROINTESTINAL INFECTIONS},
year = {2015},
doi = {10.5005/jp-jogi-5-1-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
CRC Press eBooks 2024
Citation only
Gut Microbiome Dysbiosis and Cancer Risk
Frontiers in Cellular Neuroscience 2022
Open access · CC-BY
A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation
International Journal of Molecular Sciences 2022
Open access · CC-BY
Gut Microbiome Changes in Gestational Diabetes
Microorganisms 2019
Open access · CC-BY
The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions
Antioxidants 2024
Open access · CC-BY
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases
EBioMedicine 2019
Open access · CC-BY